These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19442179)

  • 1. Tachykinin receptors as therapeutic targets in stress-related disorders.
    Ebner K; Sartori SB; Singewald N
    Curr Pharm Des; 2009; 15(14):1647-74. PubMed ID: 19442179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.
    Longmore J; Hill RG; Hargreaves RJ
    Can J Physiol Pharmacol; 1997 Jun; 75(6):612-21. PubMed ID: 9276138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
    Griebel G
    Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist.
    Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Terracciano R; Fincham CI; Manzini S
    Eur J Pharmacol; 1998 Jan; 341(2-3):201-9. PubMed ID: 9543241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
    Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
    Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.
    Goldhill J; Angel I
    Eur J Pharmacol; 1998 Dec; 363(2-3):161-8. PubMed ID: 9881585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for tachykinins in female mouse and rat reproductive function.
    Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
    Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of tachykinin receptors.
    Burcher E
    Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):539-43. PubMed ID: 2548782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.
    Maggi CA; Patacchini R
    Br J Pharmacol; 1992 Aug; 106(4):888-92. PubMed ID: 1327390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
    Lecci A; Capriati A; Altamura M; Maggi CA
    Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
    Fisher L; Pennefather JN
    Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinins and tachykinin receptors: structure and activity relationships.
    Almeida TA; Rojo J; Nieto PM; Pinto FM; Hernandez M; Martín JD; Candenas ML
    Curr Med Chem; 2004 Aug; 11(15):2045-81. PubMed ID: 15279567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough.
    Advenier C; Lagente V; Boichot E
    Eur Respir J; 1997 Aug; 10(8):1892-906. PubMed ID: 9272936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.